Jornadal, Misonilyn .

HRN: 22-91-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2023
CEFUROXIME 1.5GM (VIAL)
06/02/2023
06/08/2023
IV
1.5 G
On Call To OR
For Repeat CS
Waiting Final Action 
06/03/2023
CEFUROXIME 1.5GM (VIAL)
06/03/2023
06/06/2023
IV
1.5g
X 3 Doses
S/P CS
Waiting Final Action 
06/03/2023
CEFUROXIME 500MG (TAB)
06/03/2023
06/10/2023
PO
500mg
BID
S/P CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: